- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Accentia Biopharmaceuticals Inc
+ Add to WatchlistABPI:US
0.0140 USD 0.0040 22.22%As of 20:10:00 ET on 05/24/2013.
Snapshot for Accentia Biopharmaceuticals Inc (ABPI)
| Open: | 0.0141 | Day's Range: | 0.0119 - 0.0149 | Volume: | 303,200 |
|---|---|---|---|---|---|
| Previous Close: | 0.0180 | 52wk Range: | 0.0110 - 0.2800 | 1-Yr Rtn: | -94.62% |
Key Statistics for ABPI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.2480 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1.26 |
| Shares Outstanding (M) | 89.76 |
| 30 Day Average Volume | 196,848 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.3448 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABPI
Company Profile & Key Executives for ABPI
Accentia Biopharmaceuticals Inc. develops and commercializes late-stage clinical products in the therapeutic areas of respiratory disease and oncology. The Company has product candidates in clinical trials.
| Francis E O'Donnell JrChairman | Carlos F SantosChief Science Officer |
| Douglas W CalderVP:Capital Markets | James A McNultyTreasurer/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABPI News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page